Healthcare is undergoing a major technological transformation, and it is wise for the industry to leverage new and innovative tech to generate track novel data. Accumulation of data helps researchers, entrepreneurs, clinicians, and consumers to better understand both health and disease. In this case, digital biomarkers act as an opportunity to interpret new data sources into informative, actionable insights.
Based out of Nijmegen, Orikami is changing the world with smart algorithms by creating and deploying digital biomarkers that can make health care both more personal and more affordable. Patients get quicker access to effective treatment, leading to reduced waste and better treatment outcomes. Healthy.Capital’s investment will help Orikami offer personalised care to its first 25,000 patients.